| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.2 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |